ATTORNEYS AT LAW

Cases
Who We Are
- Scott+Scott LLP is a nationally recognized law firm headquartered in Connecticut with offices in New York City, Ohio and California. The firm represents individual as well as institutional investors who have suffered from corporate stock fraud. Scott+Scott has participated in recovering billions of dollars and achieved precedent-setting reforms in corporate governance on behalf of its clients. In addition to being involved in complex shareholder securities and corporate governance actions, Scott+Scott also has a significant national practice in antitrust, ERISA, consumer, civil rights and human rights litigation. Through its efforts, Scott+Scott promotes corporate social responsibility… read more
Our Practice
- Securities Fraud + Corporate Governance +
  
  Scott + Scott is a nationally recognized law firm that recovers money for individual and institutional… read more
- Antitrust +
  
  The firm is actively involved in litigating many complex antitrust cases throughout the United States… read more
- Consumer Rights +
  
  Scott + Scott regularly represents aggrieved consumers in a variety of class action cases… read more
- Employee Benefits (ERISA) +
  
  Scott + Scott actively litigates complex class actions across the United States on behalf of corporate employees… read more
- Civil Rights Litigations +
  
  Scott+Scott has also successfully litigated cases to enforce its clients’ civil rights… read more
Attorneys
- The attorneys in our firm are a diverse and accomplished group, with degrees from a variety of law schools, including Yale University, University of Wisconsin, University of Connecticut, University of Kentucky, New York University, University of Chicago, Temple University, George Washington University, University of Washington, University of San Diego, University of California, Ohio State University, Boston College and Boston University. Many graduated with distinction and were members and editors of their respective schools' law reviews, moot courts or honor fraternities. Several have served federal or state judicial clerkships. Others hold graduate degrees in law, tax or other disciplines… read more
Newsletters
Pressbox
- Scott+Scott LLP maintains a regular media presence, publishing informative articles on a regular basis, as well as appearing frequently in the news… read more
- NCPERS Reception +
FAQ
- The following questions and answers provide general information about securities class actions, derivitive litigation, and ERISA class actions. They are not legal advice.
- Securities Class Actions +
- Securities Class Actions and the non-U.S. Investor +
- Shareholder Derivative Actions +
- Antitrust Actions +
- ERISA 401(k)/Pension Retirement Benefit Class Actions +
Contact Us
- Connecticut
  
  Scott+Scott LLP
  156 South Main Street
  P.O. Box 192
  Colchester, CT 06415
  800.404.7770 toll-free
  860.537.5537 voice
  860.537.4432 fax
- California
  
  Scott+Scott LLP
  707 Broadway
  Suite 1000
  San Diego, CA 92101
  800.332-2259 toll-free
  619.233.4565 voice
  619.233.0508 fax
- Ohio
  
  Scott+Scott LLP
  12434 Cedar Road
  Suite 12
  Cleveland Heights, OH 44106
  216.229.6088 voice
  216.229.6092 fax
- New York
  
  Scott+Scott LLP
  The Chrysler Building
  405 Lexington Ave
  40th Floor
  New York, NY 10174-4099
  800.404.7770 toll-free
  212.223.6444 voice
  212.223.6334 fax
- *Virginia Annex Office
  
  Scott+Scott LLP
  103 Banbury Road
  Richmond, VA 23221
  860.537.5537 VOICE
  
  860.537.4432 FAX
- *Los Angeles Annex Office
  
  Scott+Scott LLP
  6424 Santa Monica Boulevard
  Los Angeles, CA 90038
  213.985.1274 VOICE
  
  213.985.1278 FAX
  
  scottlaw@scott-scott.com
  
  UK Tel: 0808 234 1396
Search
- Go

CASES

China Medical Technologies, Inc.

Class Period: Nov 26, 2007 to Dec 12, 2011

Lead Plaintiff Deadline: Feb 17, 2012 + Deadline passed

Summary of Case:

A securities class action has been filed against China Medical Technologies, Inc. ("China Medical" or the "Company") on behalf of all persons who purchased American Depository Shares ("ADS") of China Medical between November 26, 2007 and December 12, 2011. This case has been filed in the USDC - New York (Southern).

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and or failed to disclose that: (1) the Company's acquisition of Beijing Bio-Ekon Biotechnology Co. Ltd. ("BBE") was from a third party seller connected to China Medical's Chairman, Wu Xiaodong; (2) the Company overpaid approximately $20 million to acquire BBE; (3) the Company's acquisition of BBE involved the use of fraudulent shell companies; (4) BBE was suffering operating losses prior to the acquisition; (5) the Company overstated accounts receivables in order to inflate sales and net income; (6) the Company's reported profit margins were inflated; and (7) as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times.

On December 6, 2011, Glaucus Research Group published an analyst report revealing, in part, that China Medical's Chief Executive Officer was embezzling money through sham acquisitions, the Company's reported profits and net income were inflated as they were inconsistent with comparable competitors, and the majority of the Company's account receivables were in excess of 120 days, indicating that its reported revenues were inflated. On this news, China Medical's shares declined $0.81 per share, or nearly 24%, to close on December 6, 2011 at $2.57 per share, on unusually heavy trading volume.

On December 13, 2011, China Medical disclosed that the Company intends to implement a debt restructuring plan to improve its balance sheet. On this news, China Medical's shares declined $0.43 per share, or nearly 13%, to close on December 13, 2011 at $2.87 per share, on unusually heavy trading volume.

If you purchased this company's shares during the Class Period and suffered a loss or for further information about the case, please review the links below.